Tarantino et al. reviewed 5235 stages I–III HER2-negative breast cancer cases operated at Dana-Faber/Brigham Cancer Center and found a clear association of HER2-low expression with low tumor grade and high ER expression, but no significant difference in clinical or pathological parameters19. The gene discussed is ERBB2; the disease is breast carcinoma.